MUFG Americas’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-330
| Closed | -$227K | – | 647 |
|
|
2022
Q3 | $227K | Sell |
330
-512
| -61% | -$352K | 0.01% | 365 |
|
|
2022
Q2 | $498K | Sell |
842
-80
| -9% | -$47.3K | 0.01% | 310 |
|
|
2022
Q1 | $644K | Sell |
922
-64
| -6% | -$44.7K | 0.01% | 294 |
|
|
2021
Q4 | $623K | Sell |
986
-56
| -5% | -$35.4K | 0.01% | 302 |
|
|
2021
Q3 | $631K | Sell |
1,042
-248
| -19% | -$150K | 0.01% | 294 |
|
|
2021
Q2 | $721K | Sell |
1,290
-396
| -23% | -$221K | 0.01% | 284 |
|
|
2021
Q1 | $798K | Sell |
1,686
-1,376
| -45% | -$651K | 0.01% | 286 |
|
|
2020
Q4 | $1.48M | Sell |
3,062
-2,393
| -44% | -$1.16M | 0.03% | 237 |
|
|
2020
Q3 | $3.05M | Sell |
5,455
-485
| -8% | -$272K | 0.08% | 185 |
|
|
2020
Q2 | $3.71M | Sell |
5,940
-6,094
| -51% | -$3.8M | 0.11% | 168 |
|
|
2020
Q1 | $5.88M | Sell |
12,034
-2,624
| -18% | -$1.28M | 0.2% | 124 |
|
|
2019
Q4 | $5.5M | Buy |
14,658
+477
| +3% | +$179K | 0.14% | 154 |
|
|
2019
Q3 | $3.93M | Buy |
14,181
+1,590
| +13% | +$441K | 0.11% | 177 |
|
|
2019
Q2 | $3.94M | Buy |
12,591
+3,344
| +36% | +$1.05M | 0.11% | 182 |
|
|
2019
Q1 | $3.8M | Buy |
9,247
+7,202
| +352% | +$2.96M | 0.11% | 177 |
|
|
2018
Q4 | $764K | Buy |
+2,045
| New | +$764K | 0.02% | 276 |
|
|
2015
Q4 | – | Sell |
-9
| Closed | -$4K | – | 1175 |
|
|
2015
Q3 | $4K | Buy |
+9
| New | +$4K | ﹤0.01% | 1002 |
|
|
2015
Q2 | – | Sell |
-30
| Closed | -$14K | – | 1256 |
|
|
2015
Q1 | $14K | Sell |
30
-15
| -33% | -$7K | ﹤0.01% | 868 |
|
|
2014
Q4 | $18K | Sell |
45
-22
| -33% | -$8.8K | ﹤0.01% | 844 |
|
|
2014
Q3 | $24K | Hold |
67
| – | – | ﹤0.01% | 793 |
|
|
2014
Q2 | $19K | Sell |
67
-13
| -16% | -$3.69K | ﹤0.01% | 852 |
|
|
2014
Q1 | $24K | Buy |
+80
| New | +$24K | ﹤0.01% | 795 |
|